| RS140294059 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS140294222 |
G6PC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS1402948915 |
ACBD5
|
Health Risk |
Pathogenic |
— |
| RS1402952523 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1402953071 |
ZMPSTE24
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS140296036 |
PYGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type VI |
| RS140296295 |
HMCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 1, Age related macular degeneration 1 |
| RS140296609 |
RBM10
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1402966846 |
ALDOB
|
Health Risk |
Pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS1402967241 |
CLCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140296831 |
IGHMBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS1402968787 |
DVL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DVL3-related disorder |
| RS140298514 |
CD46
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly |
| RS140299014 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS1402990329 |
WNT10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Tooth agenesis, selective |
| RS140299648 |
SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hypersulfaturia |
| RS140299861 |
AMER1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1402999203 |
WFS1
|
Health Risk |
Likely pathogenic |
Wolfram syndrome 1, Wolfram syndrome 1 |
| RS140300282 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1403009542 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS140301218 |
MYO3A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140303247 |
SLC16A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS1403034076 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1403034524 |
PRRT2
|
Health Risk |
Pathogenic |
Episodic kinesigenic dyskinesia 1, Episodic kinesigenic dyskinesia 1 |
| RS1403042622 |
MME
|
Health Risk |
Likely pathogenic |
— |
| RS140304758 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS140304897 |
SARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperuricemia, pulmonary hypertension |
| RS1403055370 |
CTDP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140305765 |
CDC20
|
Health Risk |
Pathogenic |
Oocyte maturation defect 14, Oocyte maturation defect 14 |
| RS140306279 |
FAM111A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140306846 |
ALOX12B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140306974 |
CEP120
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 13 with or without polydactyly, Inborn genetic diseases |
| RS1403076049 |
PROS1
|
Health Risk |
Pathogenic |
Thrombophilia due to protein S deficiency, autosomal recessive |
| RS140307657 |
CFAP44
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140307681 |
DGUOK
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), Portal hypertension |
| RS140307699 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS140308322 |
ALDH6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonate semialdehyde dehydrogenase deficiency, Methylmalonate semialdehyde dehydrogenase deficiency |
| RS140308808 |
WDR35
|
Health Risk |
Conflicting classifications of pathogenicity |
Cranioectodermal dysplasia 2, Short-rib thoracic dysplasia 7 with or without polydactyly |
| RS140308982 |
VCL
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1W, Cardiovascular phenotype |
| RS140309338 |
GLIS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal diabetes mellitus with congenital hypothyroidism, Neonatal diabetes mellitus with congenital hypothyroidism |
| RS1403101337 |
NHLRC1
|
Health Risk |
Likely pathogenic |
Lafora disease, Lafora disease |
| RS1403112959 |
OTOF
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS140311741 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, NOTCH2-related disorder |
| RS1403123573 |
DPAGT1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 13, Congenital myasthenic syndrome 13 |
| RS140312372 |
CLCN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Dent disease type 1, Dent disease type 1 |
| RS1403125636 |
PLA2G6
|
Health Risk |
Pathogenic |
Infantile neuroaxonal dystrophy, Autosomal recessive Parkinson disease 14 |
| RS1403129366 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS140313460 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Connective tissue disorder |
| RS1403136669 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS1403144024 |
ALPK3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, familial hypertrophic 27 |
| RS140315493 |
FMN2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1403155983 |
ALX4
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS140315637 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1403162016 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS140316223 |
HELLS
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 4, Immunodeficiency-centromeric instability-facial anomalies syndrome 4 |
| RS1403165900 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Epilepsy with myoclonic atonic seizures |
| RS140316904 |
KITLG
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140317309 |
LONP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140317484 |
SLC3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystinuria, Cystinuria |
| RS140317494 |
GATA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital heart defects, multiple types |
| RS140317560 |
RAD51D
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS140317692 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140318156 |
FOCAD
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140318342 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Connective tissue disorder |
| RS1403186964 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS140319056 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS140319117 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS140319442 |
EGF
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal hypomagnesemia 4, Renal hypomagnesemia 4 |
| RS140319509 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS1403211358 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Brugada syndrome 1 |
| RS140321570 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140322336 |
TPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of iodide peroxidase, TPO-related disorder |
| RS140322345 |
ILK
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, ILK-related disorder |
| RS140322984 |
BCKDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1403231932 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS140323384 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 12, Asphyxiating thoracic dystrophy 4 |
| RS1403242422 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS140324769 |
BMP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, BMP1-related disorder |
| RS140325029 |
LAMC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS140326154 |
DNAI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 9, Primary ciliary dyskinesia |
| RS140326236 |
LHFPL5
|
Health Risk |
Conflicting classifications of pathogenicity |
LHFPL5-related disorder, LHFPL5-related disorder |
| RS140327327 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS140328142 |
ACSF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia, Combined malonic and methylmalonic acidemia |
| RS140328152 |
FERMT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukocyte adhesion deficiency 3, Inborn genetic diseases |
| RS1403288739 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Usher syndrome type 1 |
| RS140329381 |
GLA;RPL36A-HNRNPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Migalastat response |
| RS1403296082 |
APOA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1403300887 |
DDX59
|
Health Risk |
Pathogenic |
— |
| RS140330283 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated Nonsyndromic Congenital Heart Disease, Alagille syndrome due to a JAG1 point mutation |
| RS140330831 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS140331348 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS140331410 |
PACS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 66 |
| RS140331414 |
POLH
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum variant type, Xeroderma pigmentosum |
| RS1403318277 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
8 conditions, Hereditary cancer-predisposing syndrome |
| RS140332077 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS1403323591 |
PKLR
|
Health Risk |
Conflicting classifications of pathogenicity |
PKLR-related disorder, PKLR-related disorder |
| RS140332366 |
GJA3
|
Health Risk |
Likely pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS140332932 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-related disorder, FLNB-related disorder |
| RS140334403 |
CDAN1
|
Health Risk |
Likely pathogenic |
Congenital dyserythropoietic anemia, type I |
| RS140334418 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis Imperfecta |